Inscription à l’infolettre

Publications

Publications récentes

Voir les publications précédentes
  • 4 March 2019

    IPIP27 Coordinates PtdIns(4,5)P2 Homeostasis for Successful Cytokinesis.

    Carim SC, Ben El Kadhi K, Yan G, Sweeney ST, Hickson GR, Carréno S, Lowe M
    Curr. Biol. 2019-03-04 ;29( 5 ):775-789.e7

  • 1st March 2019

    Drug combinations: a strategy to extend the life of antibiotics in the 21st century.

    Tyers M, Wright GD
    Nat. Rev. Microbiol. 2019-03-01 ;17( 3 ):141-155

  • 1st March 2019

    Dynamic Phosphoproteomics Uncovers Signaling Pathways Modulated by Anti-oncogenic Sphingolipid Analogs.

    Kubiniok P, Finicle BT, Piffaretti F, McCracken AN, Perryman M, Hanessian S, Edinger AL, Thibault P
    Mol. Cell Proteomics 2019-03-01 ;18( 3 ):408-422

  • 1st March 2019

    Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.

    Urtishak KA, Wang LS, Culjkovic-Kraljacic B, Davenport JW, Porazzi P, Vincent TL, Teachey DT, Tasian SK, Moore JS, Seif AE, Jin S, Barrett JS, Robinson BW, Chen IL, Harvey RC, Carroll MP, Carroll AJ, Heerema NA, Devidas M, Dreyer ZE, Hilden JM, Hunger SP, Willman CL, Borden K, Felix CA
    Oncogene 2019-03-01 ;38( 13 ):2241-2262

  • 1st March 2019

    Loss-of-function mutations in KIF14 cause severe microcephaly and kidney development defects in humans and zebrafish.

    Reilly ML, Stokman MF, Magry V, Jeanpierre C, Alves M, Paydar M, Hellinga J, Delous M, Pouly D, Failler M, Martinovic J, Loeuillet L, Leroy B, Tantau J, Roume J, Gregory-Evans CY, Shan X, Filges I, Allingham JS, Kwok B, Saunier S, Giles RH, Benmerah A
    Hum. Mol. Genet. 2019-03-01 ;28( 5 ):778-795

  • 28 February 2019

    A topological view of human CD34+ cell state trajectories from integrated single-cell output and proteomic data.

    Knapp D, Hammond CA, Wang F, Aghaeepour N, Miller PH, Beer PA, Pellacani D, VanInsberghe M, Hansen C, Bendall SC, Nolan GP, Eaves CJ
    Blood 2019-02-28 ;133( 9 ):927-939

  • 26 February 2019

    Complex karyotype AML displays G2/M signature and hypersensitivity to PLK1 inhibition.

    Moison C, Lavallée VP, Thiollier C, Lehnertz B, Boivin I, Mayotte N, Gareau Y, Fréchette M, Blouin-Chagnon V, Corneau S, Lavallée S, Lemieux S, Marinier A, Hébert J, Sauvageau G
    Blood Adv 2019-02-26 ;3( 4 ):552-563

  • 19 February 2019

    ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation.

    Shin S, Buel GR, Nagiec MJ, Han MJ, Roux PP, Blenis J, Yoon SO
    Proc. Natl. Acad. Sci. U.S.A. 2019-02-19 ;116( 8 ):2967-2976

Voir plus de publications